$4 Million
Settlement
Mass Torts
$203 Million
Class Action
Financial Services
$75 Million
Class Action
Mass Torts
$200 Million
Class Action
Product Liability
Recalled Philips Respironics Bi-Level CPAPs and Ventilators Are Allegedly Linked to Serious Illness
For years, Philips has been a trusted name in medical equipment manufacturing. However, a recent recall has caused many patients to question the safety of their Philips continuous positive airway pressure machines (CPAPs) and ventilator devices. After complaints of headaches and respiratory problems and internal testing by Philips researchers, the company has found that many of their bi-level CPAP and ventilator products could be harmful to patients’ health. Specifically, many of their CPAP and ventilator models include sound abatement foam that has been shown to break down over time and use. This foam can aerosolize, enter the airway of the device, and be inhaled by the patient. The foam has also been proven to off-gas certain harmful chemicals which are then inhaled. The Philips bi-level CPAP and ventilator models that are affected include the popular Generation 1 Dreamstation line. Philips claims the Dreamstation 2 line is unaffected.
Although Philips has investigated the issue and issued a recall, patients still deserve recompense for their medical bills and their need for a safe, new ventilator. The Food and Drug Administration (FDA) has released a statement urging patients and healthcare providers to re-evaluate the CPAP machine or ventilator used in their care plans to avoid potential health risks from using a Philips bi-level CPAP or ventilator.
If you have been diagnosed with an illness linked to using a Philips CPAP, BiPAP, or ventilator machine, contact our Mass Tort team today by completing the form or calling (855) 997-1518.
Polyester-Based Polyurethane (PE-PUR) Sound Abatement Foam Could Cause Harmful Side Effects
The breakdown of PE-PUR sound abatement foam in Philips CPAP and ventilator devices is highly dangerous as patients can easily ingest or inhale chemicals directly for long periods of time. Potential risks of inhalation could include:
- Headaches
- Nausea or vomiting
- Respiratory irritation
- Hypersensitivity
The Philips investigation into PE-PUR off-gassing has even uncovered possible carcinogenic risks. The American Academy of Sleep Medicine warns that those who can safely do so should immediately cease their use of their affected Philips CPAP or ventilator device. Otherwise, patients should discuss a new plan of care with their healthcare provider as soon as possible.
According to the FDA, the Philips Respironics CPAP and ventilator models that have been recalled include the following:
- E30
- DreamStation ASV
- DreamStation AT, AVAPS
- SystemOne ASV4
- C-Series ASV
- C-Series S/T and AVAPS
- OmniLab Advanced+
- SystemOne Q-Series
- DreamStation
- DreamStation Go
- Dorma 400
- Dorma 500
- REMstar SE Auto
- Trilogy 100
- Trilogy 200
- Garbin Plus, Aeris, LifeVent
- A-Series BiPAP V30 Auto
- A-Series BiPAP A40
- A-Series BiPAP A30
If you have been using any of the listed Philips CPAP, BiPAP, or ventilator models and have developed an illness linked to its use, we want to speak to you. Contact us by filling out the form or calling (855) 997-1518 today.
Legal Protection from Dangerous Medical Devices
For decades, McCune Law Group, has assisted consumers and patients across the country when faulty and dangerous products cause harm. With millions recovered for our clients who have suffered from illness and injury due to faulty drugs and medical devices, the Mass Torts team at MLG can help you seek justice.
If you or your loved one uses a Philips Respironics CPAP, BiPAP, or ventilator machine and has recently developed an illness linked to its use, let us work for you. Contact MLG by completing the form or calling (855) 997-1518 today!
Attorney Handling this Case
At McCune Law Group, Kristy M. Arevalo has established herself as one of the Inland Empire’s top plaintiff’s attorneys in the legal fields of medical product failure, personal injury, wrongful death, and product liability.
Ms. Arevalo is dedicated to obtaining just redress for her clients while holding individuals, corporations, and entities responsible for defective and dangerous actions, products, and pharmaceuticals. She has litigated and settled multiple cases involving the recalled DePuy ASR hips and is active in many multidistrict and coordinated litigations around the country involving defective drugs and medical devices, such as DePuy Pinnacle hips, Wright Medical hips, Inferior Vena Cava (IVC) filters, Hernia Mesh and Essure birth control.
In addition to her mass torts practice, Ms. Arevalo handles catastrophic personal injury and wrongful death cases. She has argued in front of the California Court of Appeals and has tried multiple cases to verdict.
Ms. Arevalo grew up in Southern California and graduated with honors from the University of California, Irvine. Immediately after graduating from Loyola Law School in Los Angeles, California, Ms. Arevalo joined McCune Law Group. For over 17 years she has worked diligently to help those who have been injured or wronged.
In addition to her busy litigation practice, Ms. Arevalo is actively involved in the Consumer Attorneys of California (CAOC) and is a graduate of CAOC’s 2015 Leadership Academy. She is President of the Inland Empire Chapter of CAOC, Legislative Chair of the CAOC Diversity Committee, on the Board of Governor’s of CAOC, and involved in the CAOC Women’s Caucus. She was selected to the California Rising Stars list in 2016, an honor bestowed on less than 2% of California attorneys aged 40 and younger. Ms. Arevalo is also a regular speaker at conferences on the subjects of mass torts, product liability, personal injury and commercial litigation.